Hostinger Introduces Coupon Code for First Time Users to Get 20% Off via HostVerify.co
Quality Clouds Launches Hub: Enterprise-Grade Governance for AI-Generated Code
SPA InterContinental and VALMONT Unveil Thailand’s First Full Face & Body Luxury Treatment Experience
Unitree IPO Registration Approved: Shoucheng Holdings’ Robotics Investment Enters Value Realization Phase
Enablence Technologies Announces Adoption of Equity Incentive Plan
Kathleen Lynch has joined as Head of Global Government Affairs and Communications and Michele Farmer has…
– Recent New Drug Application Resubmission for XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) – –…
REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage…
KIN-2787 is the company’s RAF inhibitor candidate for patients with mutant BRAF-driven solid tumors Planned…
FLT190 Phase 1/2 dose-finding study in Fabry disease on track to dose additional patients; Company to…
Company to host conference call at 5:00 p.m. ET MENLO PARK, Calif., May 17, 2021…
The National Institute of Allergy and Infectious Diseases will fund the continued clinical development of…
CAMBRIDGE, Mass., May 17, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage…
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
NEWTON, Mass., May 17, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
Advancing two lead product candidates in Phase 1/2 clinical trials Completed successful $126M initial public…
Advicenne receives positive feedback from the US FDA on pathway to approval and amended Phase…
Advicenne reçoit un avis positif de la FDA sur la procédure d’approbation et l’Agence accepte…
Company announcement no. 16 – 2117 May 2021 NTG Nordic Transport Group publishes interim report…
Decision not to review Federal Circuit July 2020 ruling continues to prevent Sandoz launch of…
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 17 May 2021 – On 7…
UPPSALA, SWEDEN – LIDDS Annual General Meeting (AGM) was held on May 17, 2021….
Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduced asthma attacks…
TORONTO, May 17, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…